Aleksandra Winiarz
Overview
Explore the profile of Aleksandra Winiarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duenweg S, Bobholz S, Lowman A, Winiarz A, Nath B, Barrett M, et al.
Front Oncol
. 2025 Feb;
15:1433444.
PMID: 39990680
Objectives: Intensity variation in multi-parametric magnetic resonance imaging (MP-MRI) is a confounding factor in MRI analyses. Previous studies have employed several normalization methods, but there is a lack of consensus...
2.
Bobholz S, Aaronsen D, Winiarz A, Duenweg S, Lowman A, Flatley M, et al.
Neuro Oncol
. 2025 Feb;
PMID: 39960860
Introduction: This study determines the relationship between diffusion and perfusion-based MRI signatures and radio-pathomic maps of tumor pathology in a large, multi-site cohort. Methods: This study included perfusion imaging from...
3.
Bobholz S, Lowman A, Connelly J, Duenweg S, Winiarz A, Nath B, et al.
Neurosurgery
. 2024 Mar;
95(3):537-547.
PMID: 38501824
Background And Objectives: This study identified a clinically significant subset of patients with glioma with tumor outside of contrast enhancement present at autopsy and subsequently developed a method for detecting...
4.
Bobholz S, Hoefs A, Hamburger J, Lowman A, Winiarz A, Duenweg S, et al.
J Neurooncol
. 2024 Mar;
167(2):243.
PMID: 38498261
No abstract available.
5.
Bobholz S, Hoefs A, Hamburger J, Lowman A, Winiarz A, Duenweg S, et al.
J Neurooncol
. 2024 Feb;
167(2):233-241.
PMID: 38372901
Background: Autopsy-based radio-pathomic maps of glioma pathology have shown substantial promise inidentifying areas of non-enhancing tumor presence, which may be able to differentiate subsets of patients that respond favorably to...
6.
Bobholz S, Hoefs A, Hamburger J, Lowman A, Winiarz A, Duenweg S, et al.
Res Sq
. 2024 Jan;
PMID: 38260400
Background: Autopsy-based radio-pathomic maps of glioma pathology have shown substantial promise inidentifying areas of non-enhancing tumor presence, which may be able to differentiate subsets of patients that respond favorably to...
7.
Duenweg S, Brehler M, Lowman A, Bobholz S, Kyereme F, Winiarz A, et al.
Lab Invest
. 2023 Oct;
103(12):100269.
PMID: 37898290
Prostate cancer is the most commonly diagnosed cancer in men, accounting for 27% of the new male cancer diagnoses in 2022. If organ-confined, removal of the prostate through radical prostatectomy...
8.
Duenweg S, Bobholz S, Barrett M, Lowman A, Winiarz A, Nath B, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760407
Prostate cancer (PCa) is the most diagnosed non-cutaneous cancer in men. Despite therapies such as radical prostatectomy, which is considered curative, distant metastases may form, resulting in biochemical recurrence (BCR)....
9.
Duenweg S, Bobholz S, Lowman A, Stebbins M, Winiarz A, Nath B, et al.
J Pathol Inform
. 2023 Jul;
14:100321.
PMID: 37496560
Purpose: Digital pathology is becoming an increasingly popular area of advancement in both research and clinically. Pathologists are now able to manage and interpret slides digitally, as well as collaborate...
10.
Duenweg S, Brehler M, Bobholz S, Lowman A, Winiarz A, Kyereme F, et al.
PLoS One
. 2023 Mar;
18(3):e0278084.
PMID: 36928230
One in eight men will be affected by prostate cancer (PCa) in their lives. While the current clinical standard prognostic marker for PCa is the Gleason score, it is subject...